Bellon Steven F.

Bellon Steven F. is listed in filings as Chief Scientific Officer at Foghorn Therapeutics Inc.. This profile follows SEC Form 4 activity through Feb 2, 2026, including sale activity. Recent filings connect the profile to Foghorn Therapeutics Inc. (FHTX). The current snapshot covers public activity from Sep 11, 2024 to Feb 2, 2026. Reported amounts are shown as $1.7M to $190.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.